MARIA CONSUELO MONTEJO RUBIO

Has grant

Researcher (Academic)/ Full Professor of Pharmacy and Pharmaceutical Technology at San Pablo CEU University

Universidad CEU San Pablo

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Drug Delivery Drug Delivery professors in Spain

Contact this professor

LinkedIn

Google Scholar

About

Maria Consuelo Montejo Rubio is a Full Professor of Pharmacy and Pharmaceutical Technology at Universidad CEU San Pablo in Spain. Her research focuses on innovative drug delivery systems, including the development of nanoparticles and microparticles for targeted therapies in conditions such as cancer and inflammatory diseases. Recent publications include studies on cannabidiol formulations and novel approaches to pharmacokinetic data analysis.

Recent Grants

Grant: Close

Nanofármacos mesoporosos organosiliceos con actividad anticancerígena inherente. PID2021-125216OB-I00.

Open Date: 2022-09-01

Close Date: 2025-12-01

Grant: Close

Nanotransportadores lipidicos funcionalizados con cannabidiol para el tratamiento de tumores cerebrales. PID2019-105531RB-I00

Open Date: 2020-06-01

Close Date:

Grant: Close

Papel de la vía de señalización pleitrofina/receptor proteína tirosina fosfatasa beta/zeta en procesos inflamatorios implicados en desórdenes metabólicos y neurodegenerativos. RTI2018-095615-B-I00.

Open Date: 2019-01-01

Close Date:

Grant: Close

Nanopartículas de PLGA modificadas para la vectorización de resagilina a sistema nervioso central en el tratamiento del Parkinson. PR26/16-20248

Open Date: 2017-01-01

Close Date:

Grant: Close

Caracterización de la pleiotrofina como diana terapéutica en procesos inflamatorios: Estudio comparativo en el sistema nervioso central y en tejidos periféricos. SAF2014-56671-R.

Open Date: 2015-01-01

Close Date:

Articles (9)

Cannabidiol-loaded-injectable depot formulation for the treatment of triple-negative breast cancer: design, development, in-vitro and in-ovo evaluation of its anticancer activity

Year:

2025

Regional brain distribution of PLGA nanoparticles functionalized with glutathione or phenylalanine dipeptide

Year:

2025

Correction to: Polycaprolactone microparticles for the subcutaneous administration of cannabidiol: in vitro and in vivo release

Year:

2024

Polycaprolactone microparticles for the subcutaneous administration of cannabidiol: in vitro and in vivo release

Year:

2024

Functionalization of Morin-Loaded PLGA Nanoparticles with Phenylalanine Dipeptide Targeting the Brain

Year:

2022

Celecoxib Microparticles for Inhalation in COVID-19-Related Acute Respiratory Distress Syndrome

Year:

2022

A Signal Processing Approach to Pharmacokinetic Data Analysis

Year:

2021

Sulfasalazine Microparticles Targeting Macrophages for the Treatment of Inflammatory Diseases Affecting the Synovial Cavity

Year:

2021

Potential Active Targeting of Gatifloxacin to Macrophages by Means of Surface-Modified PLGA Microparticles Destined to Treat Tuberculosis

Year:

2020

Collaborators (7)

Antonio Aguilar-Ros

Profesor Titular Farmacología

Universidad CEU San Pablo

SPAIN

Ana Isabel Torres-Suárez

Professor

Universidad Complutense de Madrid Facultad de Medicina

SPAIN

Luis García-García

Profesor Contratado Doctor

Universidad Complutense de Madrid

SPAIN

A.I. Fraguas-Sánchez

Assistant Professor

Universidad Complutense de Madrid

SPAIN

Juan Francisco González

Profesor Titular de Universidad

Universidad Complutense de Madrid

SPAIN

Mario Alonso González

Profesor Colaborador Doctor

Universidad CEU San Pablo

SPAIN

Ana Fernández-Carballido

Professor/researcher

-

SPAIN

Social connections

How do I reach out?

Sign in for free to see their profile details and contact information.

Meet Kite AI